GTC Biotherapeutics (fka GTCB)

[floblu14]

Merrimack:

1.The FDA has approved an additional 3 month clinical trial for R/A(MM-093) with an increased dosage of 60MG. (A lower dosage worked in some areas but not all.)

2. Enrollment already beginning for 60-80 patients

3. Results - end of '07

4. NO SAFETY PROBLEMS

5. Merrimack sentiments - very POSITIVE